Nature Biotechnology Podcast

missing image

Nature Biotechnology podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.

0 Likes     0 Followers     1 Subscribers

Sign up / Log in to like, follow, recommend and subscribe!

Website
http://www.nature.com/nbt/podcast/index.html
Description
Nature Biotechnology podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.
Language
🇬🇧 English
last modified
2019-06-25 14:44
last episode published
2019-05-07 14:00
publication frequency
36.0 days
Contributors
Nature Biotechnology author  
Nature Publishing Group owner  
Explicit
false
Number of Episodes
41
Rss-Feeds
Detail page
Categories
Business Science & Medicine Natural Sciences Business News

Recommendations


Episodes

Date Thumb Title & Description Contributors
7.05.2019

First Rounders: Robert Langer

Robert Langer is the David H. Koch Institute professor at the Massachusetts Institute of Technology. He also runs the Langer Lab and is co-founder of more than 40 biotech companies. His talk with Nature Biotechnology covers the death of his father, his...
Nature Biotechnology author
1.03.2019

First Rounders: George Church

George Church is professor of genetics at Harvard University, and professor of health sciences and technology at Harvard and the Massachusetts Institute of Technology. He is also co-founder of more than 20 biotech companies. His talk with Nature Biotec...
Nature Biotechnology author
1.03.2019

First Rounders: George Church

George Church is professor of genetics at Harvard University, and professor of health sciences and technology at Harvard and the Massachusetts Institute of Technology. He is also co-founder of more than 20 biotech companies. His talk with covers being...
Nature Biotechnology author
1.01.2019

First Rounders: Chad Womack

Chad Womack is senior director of STEM initiatives at UNCF. The episode covers Womack's path to HIV research at Harvard, his experience founding a biotech just before the Great Recession, and what the election of President Barack Obama meant to African...
Nature Biotechnology author
1.01.2019

First Rounders: Chad Womack

Chad Womack is senior director of STEM initiatives at UNCF. The episode covers Womack's path to HIV research at Harvard, his experience founding a biotech just before the Great Recession, and what the election of President Barack Obama meant to African...
Nature Biotechnology author
1.11.2018

First Rounders: Christoph Lengauer

Christoph Lengauer is a venture partner at Third Rock Ventures, the president of Celsius Therapeutics, and executive vice president at Blueprint Medicines. His conversation with Nature Biotechnology covers growing up in Austria, why he nearly gave up r...
Nature Biotechnology author
1.11.2018

First Rounders: Christoph Lengauer

Christoph Lengauer is a venture partner at Third Rock Ventures, the president of Celsius Therapeutics, and executive vice president at Blueprint Medicines. His conversation with Nature Biotechnology covers growing up in Austria, why he nearly gave up r...
Nature Biotechnology author
6.09.2018

First rounders: Feng Zhang

Feng Zhang runs the Zhang Lab at the Massachusetts Institute of Technology. He's also a faculty member at the Broad Institute of MIT and Harvard, and has co-founded several biotech companies, including Editas Medicine. His conversation with Nature Biot...
Nature Biotechnology author
6.09.2018

First rounders: Feng Zhang

Feng Zhang runs the Zhang Lab at the Massachusetts Institute of Technology. He's also a faculty member at the Broad Institute of MIT and Harvard, and has co-founded several biotech companies, including Editas Medicine. His conversation with Nature Biot...
Nature Biotechnology author
7.05.2018

First Rounder: John Maraganore

John Maraganore is CEO of Alnylam Pharmaceuticals. In his talk with Nature Biotechnology he discusses his decade at Biogen, running an RNAi company when skepticism covered the field, and growing up the son of Greek immigrants in Chicago.
Nature Biotechnology author
7.05.2018

First Rounder: John Maraganore

John Maraganore is CEO of Alnylam Pharmaceuticals. In his talk with he discusses his decade at Biogen, running an RNAi company when skepticism covered the field, and growing up the son of Greek immigrants in Chicago.
Nature Biotechnology author
20.02.2018

First Rounder: Jeff Leiden

Jeff Leiden is chairman, president and CEO of Vertex Pharmaceuticals. His conversation with Nature Biotechnology covers rebuilding Vertex toward cystic fibrosis, competing for talent in the innovation economy and dropping out of high school to enter co...
Nature Biotechnology author
20.02.2018

First Rounder: Jeff Leiden

Jeff Leiden is chairman, president and CEO of Vertex Pharmaceuticals. His conversation with Nature Biotechnology covers rebuilding Vertex toward cystic fibrosis, competing for talent in the innovation economy and dropping out of high school to enter co...
Nature Biotechnology author
18.12.2017

First Rounder: Susan Windham-Bannister

Susan Windham-Bannister is president and CEO of Biomedical Growth Strategies and was the founding president and CEO of the Massachusetts Life Sciences Center (MLSC). Her conversation with Nature Biotechnology covers her childhood in segregated St. Loui...
Nature Biotechnology author
18.12.2017

First Rounder: Susan Windham-Bannister

Susan Windham-Bannister is president and CEO of Biomedical Growth Strategies and was the founding president and CEO of the Massachusetts Life Sciences Center (MLSC). Her conversation with Nature Biotechnology covers her childhood in segregated St. Loui...
Nature Biotechnology author
26.10.2017

First Rounder: Stelios Papadopoulos

Stelios Papadopoulos has been a biotech analyst, investment banker, and company founder. He's the current chairman of the board at Biogen. His conversation with Nature Biotechnology touches on his reasons for leaving Greece to come to the United States...
Nature Biotechnology author
26.10.2017

First Rounder: Stelios Papadopoulos

Stelios Papadopoulos has been a biotech analyst, investment banker, and company founder. He's the current chairman of the board at Biogen. His conversation with Nature Biotechnology touches on his reasons for leaving Greece to come to the United States...
Nature Biotechnology author
18.08.2017

First Rounder: Greg Winter

Greg Winter is the Master of Trinity College, Cambridge, and a serial entrepreneur, who co-founded Cambridge Antibody Technology. Much of his career was spent at the Medical Research Council, and his research led to humanized monoclonal antibodies. His...
Nature Biotechnology author
18.08.2017

First Rounder: Greg Winter

Greg Winter is the Master of Trinity College, Cambridge, and a serial entrepreneur, who co-founded Cambridge Antibody Technology. Much of his career was spent at the Medical Research Council, and his research led to humanized monoclonal antibodies. His...
Nature Biotechnology author
8.06.2017

First Rounder: Jan Vilcek

Jan is the co-founder, CEO and chairman of the Vilcek Foundation, and also a long-time researcher and professor at New York University's School of Medicine. His conversation with Nature Biotechnology covers his harrowing childhood in Czechoslovakia dur...
Nature Biotechnology author
8.06.2017

First Rounder: Jan Vilcek

Jan is the co-founder, CEO and chairman of the Vilcek Foundation, and also a long-time researcher and professor at New York University's School of Medicine. His conversation with Nature Biotechnology covers his harrowing childhood in Czechoslovakia dur...
Nature Biotechnology author
26.04.2017

First Rounder: Rachel Haurwitz

Rachel Haurwitz is co-founder, president and CEO of Caribou Biosciences. In her discussion with Nature Biotechnology, she explains what drew her into the sciences, how her father's journalism career brought their family to Austin, Texas, and how she fo...
Nature Biotechnology author
26.04.2017

First Rounder: Rachel Haurwitz

Rachel Haurwitz is co-founder, president and CEO of Caribou Biosciences. In her discussion with Nature Biotechnology, she explains what drew her into the sciences, how her father's journalism career brought their family to Austin, Texas, and how she fo...
Nature Biotechnology author
23.02.2017

First Rounder: Stephen Quake

Stephen Quake is a professor in the department of bioengineering at Stanford University and a serial founder of biotech companies. His talk with Nature Biotechnology covers launching Fluidigm, being chosen as copresident of the Chan Zuckerberg Biohub, ...
Nature Biotechnology author
23.02.2017

First Rounder: Stephen Quake

Stephen Quake is a professor in the department of bioengineering at Stanford University and a serial founder of biotech companies. His talk with Nature Biotechnology covers launching Fluidigm, being chosen as copresident of the Chan Zuckerberg Biohub, ...
Nature Biotechnology author
20.12.2016

First Rounder: Jeremy Levin

Jeremy Levin is chairman and CEO of Ovid Therapeutics, formerly president and CEO of Teva Pharmaceutical Industries, and former member of the executive committee at Bristol-Myers Squibb, where he led that company's 'string of pearls' strategy. His conv...
Nature Biotechnology author
20.12.2016

First Rounder: Jeremy Levin

Jeremy Levin is chairman and CEO of Ovid Therapeutics, formerly president and CEO of Teva Pharmaceutical Industries, and former member of the executive committee at Bristol-Myers Squibb, where he led that company's 'string of pearls' strategy. His conv...
Nature Biotechnology author
17.11.2016

First Rounder: Anu Acharya

Anu Acharya is founder and CEO of Mapmygenome, a co-founder of Ocimum Biosolutions and a leading light for life science entrepreneurship in India. Her discussion with Nature Biotechnology covers the importance of mentorship, running a consumer genomics...
Nature Biotechnology author
17.11.2016

First Rounder: Anu Acharya

Anu Acharya is founder and CEO of Mapmygenome, a co-founder of Ocimum Biosolutions and a leading light for life science entrepreneurship in India. Her discussion with Nature Biotechnology covers the importance of mentorship, running a consumer genomics...
Nature Biotechnology author
22.09.2016

First Rounder: Nancy J Kelley

Nancy J Kelley, founder and chief executive of Nancy J Kelley + Associates, a consultancy creating and developing projects and institutions for science and medicine, touches on establishing the East River Science Park, excelling at Yale as a young moth...
Nature Biotechnology author
22.09.2016

First Rounder: Nancy J Kelley

Nancy J Kelley, founder and chief executive of Nancy J Kelley + Associates, a consultancy creating and developing projects and institutions for science and medicine, touches on establishing the East River Science Park, excelling at Yale as a young moth...
Nature Biotechnology author
19.07.2016

First Rounder: David Baltimore

David Baltimore, president emeritus of the California Institute of Technology, discusses his parents moving him from New York City to Great Neck, Long Island, as a child; his initial interest in animal virology; and getting that Nobel call from Sweden.
Nature Biotechnology author
19.07.2016

First Rounder: David Baltimore

David Baltimore, president emeritus of the California Institute of Technology, discusses his parents moving him from New York City to Great Neck, Long Island, as a child; his initial interest in animal virology; and getting that Nobel call from Sweden.
Nature Biotechnology author
26.05.2016

First Rounder: Tom Maniatis

Tom Maniatis is a founder of Kallyope, and head of the Maniatis lab at Columbia University. Among other things, he's founded several biotechs and authored a manual nicknamed 'the bible of cloning.' His conversation with Nature Biotechnology covers bein...
Nature Biotechnology author
26.05.2016

First Rounder: Tom Maniatis

Tom Maniatis is a founder of Kallyope, and head of the Maniatis lab at Columbia University. Among other things, he's founded several biotechs and authored a manual nicknamed 'the bible of cloning.' His conversation with Nature Biotechnology covers bein...
Nature Biotechnology author
10.03.2016

First Rounder: Daniel Cohen

Daniel Cohen discusses the industrialization of genomic sequencing, his part in founding Millennium and why the conductor has the most difficult job in an orchestra.
Nature Biotechnology author
22.12.2015

First Rounder: James Wilson

Nature Biotechnology talked to Wilson about his love of motocross racing, the triumphs and tribulation of gene therapy (including the Jesse Gelsinger tragedy), and the future of drug pricing.
Nature Biotechnology author
22.10.2015

First Rounder: Bill Rutter

Nature Biotechnology spoke to Rutter about building out the labs at UCSF, sequencing the hepatitis C virus and his short stint in the Navy.
Nature Biotechnology author
20.08.2015

First Rounder: Stanley Crooke

Stan Crooke discusses his troubled youth, the crests and valleys of antisense, and the skills needed to be a good leader.
Nature Biotechnology author
23.07.2015

First Rounder: Rachel King

Rachel King is president and CEO of GlycoMimetics and former chairwoman of the Biotechnology Innovation Organization. Talking with Nature Biotechnology, King discusses gene therapy, how a CEO handles layoffs and growing up with chickens.
Nature Biotechnology author
28.05.2015

First Rounder: Colin Goddard

Colin Goddard is former CEO of OSI Pharmaceuticals, and current chairman and CEO of Coferon. His conversation with Nature Biotechnology details the history behind OSI's blockbuster drug Tarceva (erlotinib), the benefits of having a British accent in th...
Nature Biotechnology author